The PGGRC approves the review, but alerts the authors to the strategic importance of not highlighting PD overly  in the review as our programme is currently investigating it further. Given that it has previously been patented and published, it is reasonable that it is included but we will need to consider how we advance this compound over the next few months before the review is published. We would request that this is given some consideration in the manner of how its presented in the review. 
